skip to main content
Idioma:
Refinado por: Base de dados/Biblioteca: Oxford Journals - CRKN remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Sorafenib in patients with Child-Pugh class A and B advanced hepatocellular carcinoma: a prospective feasibility analysis
Sorafenib in patients with Child-Pugh class A and B advanced hepatocellular carcinoma: a prospective feasibility analysis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Sorafenib in patients with Child-Pugh class A and B advanced hepatocellular carcinoma: a prospective feasibility analysis

Pressiani, T. ; Boni, C. ; Rimassa, L. ; Labianca, R. ; Fagiuoli, S. ; Salvagni, S. ; Ferrari, D. ; Cortesi, E. ; Porta, C. ; Mucciarini, C. ; Latini, L. ; Carnaghi, C. ; Banzi, M. ; Fanello, S. ; De Giorgio, M. ; Lutman, F.R. ; Torzilli, G. ; Tommasini, M.A. ; Ceriani, R. ; Covini, G. ; Tronconi, M.C. ; Giordano, L. ; Locopo, N. ; Naimo, S. ; Santoro, A.

Annals of oncology, 2013-02, Vol.24 (2), p.406-411 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
2
7O Updated results from phase I study of CC-90011 in patients (pts) with solid tumours (STs), including neuroendocrine neoplasms (NENs), and relapsed/refractory non-Hodgkin lymphoma (R/R NHL)
7O Updated results from phase I study of CC-90011 in patients (pts) with solid tumours (STs), including neuroendocrine neoplasms (NENs), and relapsed/refractory non-Hodgkin lymphoma (R/R NHL)
Material Type:
Artigo 		Adicionar ao Meu Espaço

7O Updated results from phase I study of CC-90011 in patients (pts) with solid tumours (STs), including neuroendocrine neoplasms (NENs), and relapsed/refractory non-Hodgkin lymphoma (R/R NHL)

Hollebecque, A. ; de Bono, J.S. ; Salvagni, S. ; Plummer, R. ; Niccoli, P. ; Capdevila, J. ; Curigliano, G. ; Moreno, V. ; De Braud, F. ; Gonzalez de Villambrosía, S. ; Martin-Romano, P. ; Baudin, E. ; Arias, M. ; De Alvaro, J. ; Parra-Palau, J. ; Sánchez-Pérez, T. ; Aronchik, I. ; Filvaroff, E. ; Lamba, M. ; Nikolova, Z.

Annals of oncology, 2021-03, Vol.32, p.S4-S4 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
3
528O CC-90011 in patients (Pts) with advanced solid tumours (STs) and relapsed/refractory non-Hodgkin lymphoma (R/R NHL): Updated results of a phase I study
528O CC-90011 in patients (Pts) with advanced solid tumours (STs) and relapsed/refractory non-Hodgkin lymphoma (R/R NHL): Updated results of a phase I study
Material Type:
Artigo 		Adicionar ao Meu Espaço

528O CC-90011 in patients (Pts) with advanced solid tumours (STs) and relapsed/refractory non-Hodgkin lymphoma (R/R NHL): Updated results of a phase I study

Hollebecque, A. ; de Bono, J.S. ; Salvagni, S. ; Plummer, R. ; Niccoli, P. ; Capdevila, J. ; Curigliano, G. ; Moreno, V. ; de Braud, F. ; López-Brea, M. ; Martin-Romano, P. ; Baudin, E. ; Arias, M. ; de Alvaro, J. ; Parra-Palau, J. ; Sánchez-Pérez, T. ; Aronchik, I. ; Filvaroff, E. ; Lamba, M. ; Nikolova, Z.

Annals of oncology, 2020-09, Vol.31, p.S464-S464 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
4
559P Phase Ib study of CC-90011 plus etoposide and cisplatin (EP) in patients with first-line extensive-stage (ES) small cell lung cancer (SCLC)
559P Phase Ib study of CC-90011 plus etoposide and cisplatin (EP) in patients with first-line extensive-stage (ES) small cell lung cancer (SCLC)
Material Type:
Artigo 		Adicionar ao Meu Espaço

559P Phase Ib study of CC-90011 plus etoposide and cisplatin (EP) in patients with first-line extensive-stage (ES) small cell lung cancer (SCLC)

Paz-Ares, L. ; Juan-Vidal, O. ; Carcereny, E. ; Greillier, L. ; Navarro, A. ; Bennouna, J. ; Santoro, A. ; Berardi, R. ; Besse, B. ; Salvagni, S. ; Gonzalez, H. ; de Alvaro, J. ; Parra-Palau, J. ; Sánchez-Pérez, T. ; Aronchik, I. ; Filvaroff, E. ; Lamba, M. ; Nikolova, Z. ; Ponce, S.

Annals of oncology, 2020-09, Vol.31, p.S482-S483 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
5
18O CC-90011 in patients (Pts) with advanced solid tumors (STs) and relapsed/refractory non-Hodgkin lymphoma (R/R NHL): Updated results of a phase I study
18O CC-90011 in patients (Pts) with advanced solid tumors (STs) and relapsed/refractory non-Hodgkin lymphoma (R/R NHL): Updated results of a phase I study
Material Type:
Artigo 		Adicionar ao Meu Espaço

18O CC-90011 in patients (Pts) with advanced solid tumors (STs) and relapsed/refractory non-Hodgkin lymphoma (R/R NHL): Updated results of a phase I study

Hollebecque, A. ; de Bono, J.S. ; Salvagni, S. ; Plummer, R. ; Niccoli, P. ; Capdevila, J. ; Curigliano, G. ; Moreno, V. ; De Braud, F. ; López-Brea, M. ; Martin-Romano, P. ; Baudin, E. ; Arias, M. ; De Alvaro, J. ; Parra-Palau, J. ; Sánchez-Pérez, T. ; Aronchik, I. ; Filvaroff, E. ; Lamba, M. ; Nikolova, Z.

Annals of oncology, 2020-03, Vol.31, p.S6 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
6
1383PD - Phase I study of CC-90011 in patients with advanced solid tumours (STs) and relapsed/refractory non-hodgkin lymphoma (R/R NHL)
1383PD - Phase I study of CC-90011 in patients with advanced solid tumours (STs) and relapsed/refractory non-hodgkin lymphoma (R/R NHL)
Material Type:
Artigo 		Adicionar ao Meu Espaço

1383PD - Phase I study of CC-90011 in patients with advanced solid tumours (STs) and relapsed/refractory non-hodgkin lymphoma (R/R NHL)

Hollebecque, A. ; de Bono, J.S. ; Salvagni, S. ; Plummer, R. ; Isambert, N. ; Niccoli, P. ; Capdevila, J. ; Curigliano, G. ; Moreno, V. ; De Braud, F.G.M. ; López-Brea, M. ; Martin-Romano, P. ; Baudin, E. ; Arias, M. ; de Alvaro, J. ; Parra-Palau, J. ; Sánchez Pérez, T. ; Filvaroff, E. ; Lamba, M. ; Nikolova, Z.

Annals of oncology, 2019-10, Vol.30, p.v565-v565 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
7
Phase I study of CC-90011 in patients with advanced solid tumours (STs) and relapsed/refractory non-hodgkin lymphoma (R/R NHL)
Phase I study of CC-90011 in patients with advanced solid tumours (STs) and relapsed/refractory non-hodgkin lymphoma (R/R NHL)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase I study of CC-90011 in patients with advanced solid tumours (STs) and relapsed/refractory non-hodgkin lymphoma (R/R NHL)

Hollebecque, A. ; de Bono, J.S. ; Salvagni, S. ; Plummer, R. ; Isambert, N. ; Niccoli, P. ; Capdevila, J. ; Curigliano, G. ; Moreno, V. ; De Braud, F.G.M. ; López-Brea, M. ; Martin-Romano, P. ; Baudin, E. ; Arias, M. ; de Alvaro, J. ; Parra-Palau, J. ; Sánchez Pérez, T. ; Filvaroff, E. ; Lamba, M. ; Nikolova, Z.

Annals of oncology, 2019-10, Vol.30, p.v565 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
8
Met as Prognostic Factor and Therapeutic Target in Pretreated Hepatocellular Carcinoma (HCC): Final Results of a Randomized Controlled Phase 2 Trial (RCT) with Tivantinib (ARQ 197)
Met as Prognostic Factor and Therapeutic Target in Pretreated Hepatocellular Carcinoma (HCC): Final Results of a Randomized Controlled Phase 2 Trial (RCT) with Tivantinib (ARQ 197)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Met as Prognostic Factor and Therapeutic Target in Pretreated Hepatocellular Carcinoma (HCC): Final Results of a Randomized Controlled Phase 2 Trial (RCT) with Tivantinib (ARQ 197)

Daniele, B. ; Rimassa, L. ; Porta, C. ; Borbath, I. ; Salvagni, S. ; van Laethem, J. ; van Vlierberghe, H. ; von Roemeling, R. ; Abbadessa, G. ; Santoro, A.

Annals of oncology, 2012-09, Vol.23, p.ix225 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
9
669PD - Met as Prognostic Factor and Therapeutic Target in Pretreated Hepatocellular Carcinoma (HCC): Final Results of a Randomized Controlled Phase 2 Trial (RCT) with Tivantinib (ARQ 197)
669PD - Met as Prognostic Factor and Therapeutic Target in Pretreated Hepatocellular Carcinoma (HCC): Final Results of a Randomized Controlled Phase 2 Trial (RCT) with Tivantinib (ARQ 197)
Material Type:
Artigo 		Adicionar ao Meu Espaço

669PD - Met as Prognostic Factor and Therapeutic Target in Pretreated Hepatocellular Carcinoma (HCC): Final Results of a Randomized Controlled Phase 2 Trial (RCT) with Tivantinib (ARQ 197)

Daniele, B. ; Rimassa, L. ; Porta, C. ; Borbath, I. ; Salvagni, S. ; van Laethem, J. ; van Vlierberghe, H. ; von Roemeling, R. ; Abbadessa, G. ; Santoro, A.

Annals of oncology, 2012-09, Vol.23, p.ix225-ix225 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
10
1383PDPhase I study of CC-90011 in patients with advanced solid tumours (STs) and relapsed/refractory non-hodgkin lymphoma (R/R NHL)
1383PDPhase I study of CC-90011 in patients with advanced solid tumours (STs) and relapsed/refractory non-hodgkin lymphoma (R/R NHL)
Material Type:
Artigo 		Adicionar ao Meu Espaço

1383PDPhase I study of CC-90011 in patients with advanced solid tumours (STs) and relapsed/refractory non-hodgkin lymphoma (R/R NHL)

Hollebecque, A ; de Bono, J S ; Salvagni, S ; Plummer, R ; Isambert, N ; Niccoli, P ; Capdevila, J ; Curigliano, G ; Moreno, V ; De Braud, F G M ; López-Brea, M ; Martin-Romano, P ; Baudin, E ; Arias, M ; de Alvaro, J ; Parra-Palau, J ; Sánchez Pérez, T ; Filvaroff, E ; Lamba, M ; Nikolova, Z

Annals of oncology, 2019-10, Vol.30 (Supplement_5) [Periódico revisado por pares]

Oxford University Press

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.